Late Breaking Abstract - A randomized, double-blind, placebo controlled, dose-finding trial of sulthiame in obstructive sleep apnea - Vienna 2024

Emerging insights in prognostic aspects and positive airway pressure treatment for obstructive sleep apnoea

Chair(s): Dries Testelmans, Esther Irene Schwarz

Session type: Oral presentation

Late Breaking Abstract - A randomized, double-blind, placebo controlled, dose-finding trial of sulthiame in obstructive sleep apnea

Jan A. Hedner

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - A randomized, double-blind, placebo controlled, dose-finding trial of sulthiame in obstructive sleep apnea

Jan A. Hedner

Replay

Abstract

Slides

Nightly variation in OSA severity and next day blood pressure

Bastien Lechat

Replay

Poster

Abstract

Slides

Sleep apneaspecific pulse-rate response, cardiovascular risk and response to positive airway pressure.

Margaux Blanchard

Replay

Poster

Abstract

Slides

The impact of obstructive sleep apnea on the circadian rest-activity rhythm: a cross-sectional analysis of the ELSA-Brasil cohort

Adriano D. S. Targa

Replay

Poster

Abstract

Slides

Differences in power consumption of continuous positive airway pressure (CPAP) devices

Clara Bianquis

Replay

Abstract

Slides

CPAP effects on blood pressure in different OSA phenotypes a meta-analysis

Lara Benning

Replay

Poster

Abstract

Slides

Association of positive airway pressure adherence with the burden of antihypertensive medications in hypertensive patients with sleep apnoea: data from the IRSR Pays de la Loire Sleep Cohort.

Dany Jaffuel

Replay

Poster

Abstract

Slides

Self-efficacy is an independent predictor of one-year PAP adherence trajectories

S?bastien Bailly

Replay

Poster

Abstract

Slides

CPAP effect on energy balance, chronotype, hormone, and body composition: a randomized controlled trial

Pei-lin Lee

Replay

Poster

Abstract

Slides

Effect of CPAP on circulating levels of MPO and MMP-9 in adults with coronary artery disease and obstructive sleep apnoea: the RICCADSA randomized controlled trial

Y?ksel Peker

Replay

Abstract

Slides

Discussion and Q&A

Replay

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}